Trump Tariffs Put Pharmaceuticals Next In The Crosshairs
The tariff drama hasn’t died down as President Donald Trump has just announced plans for what he calls “a major
Read moreThe tariff drama hasn’t died down as President Donald Trump has just announced plans for what he calls “a major
Read moreKits Eyecare (TSX: KITS) has released preliminary data on its first quarter results this morning, indicating that it continues to
Read moreKits Eyecare (TSX: KITS) is expecting strong first quarter 2025 financial results, announcing this morning that it has increased its
Read moreNewly confirmed US Health Secretary Robert F. Kennedy Jr. warns cannabis poses “catastrophic impacts” on users, marking an abrupt reversal
Read moreSay hello to ‘Ozempic-proof’ foods
Read moreKits Eyecare (TSX: KITS) has released preliminary results for the fourth quarter as well as the full year of 2024.
Read moreRecent social media reports have claimed that China is experiencing a severe health crisis, with hospitals and crematoriums overwhelmed by
Read moreCarebook Technologies (TSXV: CRBK) is the latest name to enter a go-private transaction. The healthtech company this morning indicated that
Read moreCanadian healthcare wait times for medically necessary treatments have hit an unprecedented high, according to the Fraser Institute’s annual Waiting
Read moreIn a development that could reshape the U.S. healthcare landscape, Walgreens Boots Alliance (NASDAQ: WBA) is reportedly in negotiations to
Read more